Sobel Alan D. 4
4 · Cytosorbents Corp · Filed May 12, 2022
Insider Transaction Report
Form 4
Sobel Alan D.
Director
Transactions
- Purchase
Common Stock
2022-05-11$2.00/sh+1,200$2,399→ 70,500 total - Purchase
Common Stock
2022-05-11$2.02/sh+8,800$17,776→ 79,300 total
Holdings
- 2,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes (i) the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015 and (ii) 10,000 shares of common stock purchased by the reporting person on May 11, 2022 and reported on this Form 4.
- [F2]These shares are held in the Bernard Sobel Revocable Trust (the "Trust"), for which the reporting person is a trustee and a named beneficiary. Accordingly, the reporting person may be deemed the beneficial owner of the shares held in the Trust.